Literature DB >> 17308137

Diagnostic and therapeutic approach to hypothalamic amenorrhea.

Alessandro D Genazzani1, Federica Ricchieri, Chiara Lanzoni, Claudia Strucchi, Valerio M Jasonni.   

Abstract

Hypothalamic amenorrhea (HA) is a secondary amenorrhea with no evidence of endocrine/systemic causal factors, mainly related to various stressors affecting neuroendocrine control of the reproductive axis. In clinical practice, HA is mainly associated with metabolic, physical, or psychological stress. Stress is the adaptive response of our body through all its homeostatic systems, to external and/or internal stimuli that activate specific and nonspecific physiological pathways. HA occurs generally after severe stress conditions/situations such as dieting, heavy training, or intense emotional events, all situations that can induce amenorrhea with or without body weight loss and HA is a secondary amenorrhea with a diagnosis of exclusion. In fact, the diagnosis is essentially based on a good anamnestic investigation. It has to be investigated using the clinical history of the patient: occurrence of menarche, menstrual cyclicity, time and modality of amenorrhea, and it has to be exclude any endocrine disease or any metabolic (i.e., diabetes) and systemic disorders. It is necessary to identify any stress situation induced by loss, family or working problems, weight loss or eating disorders, or physical training or agonist activity. Peculiar, though not specific, endocrine investigations might be proposed but no absolute parameter can be proposed since HA is greatly dependent from individual response to stressors and/or the adaptive response to stress. This article tries to give insights into diagnosis and putative therapeutic strategies.

Entities:  

Mesh:

Year:  2006        PMID: 17308137     DOI: 10.1196/annals.1365.009

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Stress and reproductive failure: past notions, present insights and future directions.

Authors:  Katrina Nakamura; Sam Sheps; Petra Clara Arck
Journal:  J Assist Reprod Genet       Date:  2008-02-15       Impact factor: 3.412

Review 2.  Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis.

Authors:  Micol S Rothman; Margaret E Wierman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 3.  A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary.

Authors:  Shannon Whirledge; John A Cidlowski
Journal:  Endocrinology       Date:  2013-09-24       Impact factor: 4.736

4.  Pituitary magnetic resonance imaging abnormalities in young female patients with hypogonadotropic hypogonadism.

Authors:  Ji-Yeon Kang; Sang Heum Kim; Hounyoung Kim; Hyojin Ki; Mee-Hwa Lee
Journal:  Obstet Gynecol Sci       Date:  2019-06-21

5.  Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology.

Authors:  Marlene Hager; Johannes Ott; Julian Marschalek; Marie-Louise Marschalek; Clemens Kinsky; Rodrig Marculescu; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2022-07-04       Impact factor: 4.982

6.  Mentha longifolia syrup in secondary amenorrhea: a double-blind, placebo-controlled, randomized trials.

Authors:  Roshanak Mokaberinejad; Nafiseh Zafarghandi; Soodabeh Bioos; Fataneh Hashem Dabaghian; Mohsen Naseri; Mohammad Kamalinejad; Gholamreza Amin; Ali Ghobadi; Mojgan Tansaz; Ali Akhbari; Mohammadali Hamiditabar
Journal:  Daru       Date:  2012-12-21       Impact factor: 3.117

7.  Effects of Gladiolus dalenii on the Stress-Induced Behavioral, Neurochemical, and Reproductive Changes in Rats.

Authors:  David Fotsing; Gwladys T Ngoupaye; Agnes C Ouafo; Stephanie K J Njapdounke; Yongabi A Kenneth; Elisabeth Ngo Bum
Journal:  Front Pharmacol       Date:  2017-09-27       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.